| Company Name | Mean Hourly | Median Hourly | Mean Bonus | Median Bonus | Latest Year | Report |
|---|---|---|---|---|---|---|
| Abbott Ireland (all legal entities) | 9.7% | 6.9% | 16.9% | 9.5% | 2024 | Report |
| AbbVie Sligo | 10% | 9.7% | 12% | 8.9% | 2024 | Report |
| AbbVie Westport (Allergan) | 9.8% | 6.3% | 3.4% | -42.9% | 2024 | Report |
| ABP Food Group: ABP Ireland | 14.7% | 7.2% | 57.3% | 0% | 2024 | Report |
| ABP Food Group: C&D Foods | 8.3% | 0% | 72.8% | 0% | 2024 | Report |
| ABP Food Group: Irish Country Meats | 10.5% | 3.5% | 44.7% | 0% | 2024 | Report |
| Aerogen | 19% | 23% | 37.7% | 23.7% | 2024 | Report |
| Alcon Ireland | 8% | 11% | 2.2% | 7.6% | 2024 | Report |
| Alexion | 17.9% | 16.2% | 26.9% | 12.6% | 2024 | Report |
| Analog Devices | 20.5% | 21.1% | 31.4% | 41.8% | 2024 | Report |
| Arrabawn | 1.3% | 12.1% | 54.85% | -118.5% | 2024 | Report |
| Astellas Ireland (all legal entities) | 5.4% | 15% | -10.6% | -5.5% | 2024 | Report |
| Aurivo Co-operative Society Ltd | 0.4% | -0.2% | -7% | -1% | 2024 | Report |
| Baxter Healthcare Ireland | 13.19% | 15.36% | 24.35% | 13.04% | 2024 | Report |
| Beckman Coulter Ireland Inc | -7.2% | -5.6% | 7.3% | 4.8% | 2023 | Report |
| BioMarin | 9.5% | 0.4% | 12.8% | -26.2% | 2024 | Report |
| BMS (BMS Ireland) | 15.4% | 14.8% | 17.1% | 7.6% | 2024 | Report |
| BMS (Swords Laboratories Ireland) | 15.7% | 16.1% | 17.1% | 6.6% | 2024 | Report |
| BOC Gases Ireland | 12% | 15% | 2% | 2% | 2024 | Report |
| Boston Scientific | 12.3% | 6.9% | 22.2% | 10.1% | 2024 | Report |
| Britvic Ireland | 0.7% | 16.3% | -18.6% | 4% | 2024 | Report |
| C&C Group Plc (all legal entities) | -8% | -9.9% | 17% | 1.6% | 2024 | Report |
| Cadence | 28.7% | 31.3% | 46% | 57.1% | 2024 | Report |
| Carbery | 2.7% | 3.5% | -16.4% | -77.6% | 2024 | Report |
| Carey Glass | 26.62% | 7.21% | -8% | 24.79% | 2024 | Report |
| Cental | -11.1% | -19.2% | No Value | No Value | 2024 | Report |
| Certa Ireland | 20.4% | 28.1% | 38.3% | 54% | 2024 | Report |
| Chanelle Pharma | 1.7% | 5.89% | 3% | No Value | 2024 | Report |
| Coca Cola Ireland | 1.9% | -8.6% | 8.5% | 6.1% | 2024 | Report |
| Cook Medical | 10.1% | 8.15% | 23.99% | 11.44% | 2024 | Report |
| Creganna Medical Ireland Limited | 12.61% | 5.11% | 12.98% | 1.26% | 2024 | Report |
| CRH: CRH Group Services Limited | 49.9% | 22.7% | 63.2% | 47.7% | 2024 | Report |
| CRH: Irish Cement | 0.03% | -5.6% | 13.61% | -11.51% | 2024 | Report |
| CRH: Roadstone | 4.5% | -1.6% | 17.7% | 11.3% | 2024 | Report |
| Dairygold | 9.8% | 9.1% | 40.1% | 38% | 2023 | Report |
| Danone Ireland | 1.5% | 2.5% | -17% | -28% | 2024 | Report |
| Dawn Farms | 2% | 4% | No Value | No Value | 2024 | Report |
| Dell Technologies Ireland: Dell Products | 13.3% | 11.1% | 23% | 24.7% | 2024 | Report |
| DePuy Ireland | -0.28% | 3.87% | -15.89% | -1.45% | 2024 | Report |
| Diageo Republic of Ireland | 6.5% | 9.5% | -1.5% | 13.4% | 2024 | Report |
| Donnelly Fresh | 8% | 3% | 55% | 0% | 2024 | Report |
| Ei Electronics | 21.2% | 1.3% | 28.1% | 9.3% | 2024 | Report |
| Eli Lilly: Kinsale | -1.9% | 7.9% | -71.6% | 6.6% | 2024 | Report |
| Embecta Ireland | 4.3% | 4.4% | -7.7% | No Value | 2023 | Report |
| Essilor - Organic Lens Manufacturing | 7.28% | 1.75% | 26.67% | 8.96% | 2024 | Report |
| Essilor - Transitions Optical Limited | 24.14% | 27.35% | 32.7% | 24.6% | 2024 | Report |
| Flextronics International | 34% | 22% | 55% | 0% | 2023 | Report |
| Freshways Food Company | 16.7% | 17.4% | No Value | No Value | 2024 | Report |
| Galco Group | -19.7% | -24.4% | No Value | No Value | 2024 | Report |
| Gilead Sciences | 7.8% | 4.7% | 15.1% | -6.4% | 2024 | Report |
| Glanbia | 37.27% | 17.02% | 68.63% | 24.21% | 2024 | Report |
| Glanmore Foods | 22.3% | 5.4% | -3% | 0% | 2024 | Report |
| Glen Dimplex Heating & Ventilation | 25% | 19% | 43% | 25% | 2023 | Report |
| Haleon (all legal entities) | 10.9% | 8.1% | 11% | 6.9% | 2024 | Report |
| Heineken Ireland | 0.7% | 3.88% | 9.09% | 5.86% | 2024 | Report |
| Henkel | 21.24% | 23.5% | 36.11% | 27.88% | 2024 | Report |
| Integer Holdings | 7.9% | 7.4% | No Value | No Value | 2024 | Report |
| Intel Ireland (Overall) | 6.5% | 7.3% | 5.8% | -11.2% | 2024 | Report |
| Irish Distillers | 7.1% | 8.7% | 5.1% | 0% | 2024 | Report |
| Jabil Ireland | 20.9% | 10.4% | 42.4% | 19.3% | 2024 | Report |
| Janssen Pharmaceutical Sciences | 14.07% | 19.98% | 23.21% | 16.01% | 2024 | Report |
| Janssen Sciences Ireland | 1.46% | 3.41% | -8.32% | -14.26% | 2024 | Report |
| Johnson & Johnson Vision Care | -0.33% | 5.69% | -17.55% | 0.38% | 2024 | Report |
| Johnson Controls: Silent-Aire | -33.1% | -15.1% | 68.4% | 48.1% | 2024 | Report |
| Johnson Controls: Tyco | 24.3% | 29.7% | 38.8% | 17.7% | 2024 | Report |
| Kellanova (Kellogg Europe Trading Limited) | 39.6% | 28.5% | 65.45% | 61.73% | 2024 | Report |
| Kepak Athleague | 7.18% | 10.12% | 55.88% | 51.26% | 2023 | Report |
| Kepak Clonee | 18.77% | 10.3% | 60.5% | 18.18% | 2023 | Report |
| Kepak Cork | 8.33% | 8.92% | 40.32% | 49.8% | 2023 | Report |
| Kepak Longford | 4.13% | 9.89% | 38.03% | 42.88% | 2023 | Report |
| Kepak McCarren Meats | 4.46% | 3.25% | 28.8% | 46.51% | 2023 | Report |
| Kerry Group | -0.3% | 6% | 17.6% | 11% | 2024 | Report |
| Kerrygold Park Butter Packing | 10% | 6% | 34% | 27% | 2024 | Report |
| Kilsaran Concrete | 3.03% | 6.95% | 27.45% | 11.74% | 2024 | Report |
| Kostal | 26.27% | 29.4% | No Value | No Value | 2023 | Report |
| Kyte Powertech Limited | 8.29% | 5.89% | 38.47% | 1.54% | 2024 | Report |
| Lakeland Dairies | 13.3% | 11% | 35.6% | -5% | 2024 | Report |
| Liffey Meats | 13.79% | 6.76% | 55.6% | 31.53% | 2023 | Report |
| Lily O'Brien's | 0% | 1% | No Value | No Value | 2024 | Report |
| Logitech | 1% | 1% | 1% | 14% | 2024 | Report |
| LotusWorks | 28% | 36.15% | 5.54% | -30.83% | 2024 | Report |
| Loughnane's Family Butchers | 15% | 11% | No Value | No Value | 2024 | Report |
| Lufthansa Technik Turbine Shannon | 14% | 18% | 8% | 6% | 2024 | Report |
| Magna International Autolaunch Ireland Limited | 4.59% | 5.93% | -266.08% | -47.74% | 2024 | Report |
| McKesson Ireland (acquired by Phoenix Group) | 22.96% | 5.01% | 65.81% | 42.49% | 2022 | Report |
| Merck Millipore | 13.7% | 18.6% | 7% | 20.5% | 2024 | Report |
| Merit Medical Ireland | 11.95% | 2.25% | 29.08% | 0% | 2024 | Report |
| Microchip Technology | 38.4% | 27.61% | 68.14% | 52.39% | 2024 | Report |
| Morehampton Foods | 13.6% | 4.6% | 39.9% | 0% | 2024 | Report |
| MSD | 6.08% | 8.74% | 11.2% | 4.34% | 2024 | Report |
| Nature's Best | 3.6% | 1.7% | No Value | No Value | 2023 | Report |
| Novartis: Novartis Ireland Limited | 16.2% | 19.1% | 25.7% | 32.7% | 2024 | Report |
| Novartis: Novartis Ringaskiddy Limited | 23.4% | 29.5% | 2.2% | 7.7% | 2022 | Report |
| O'Brien Fine Foods | 12.8% | 10.5% | 22.2% | 40.8% | 2024 | Report |
| Ornua Co-operative Ltd | 37% | 30% | 54% | 57% | 2024 | Report |
| PCI Pharma Services | 19% | 12% | 28% | 0% | 2023 | Report |
| Pepsico | 4% | 4.9% | 4.7% | -4.4% | 2024 | Report |
| Pepsico: Portfolio Concentrate Solutions | 4% | 5.2% | 3.8% | -3.4% | 2024 | Report |
| Pfizer Ireland (all legal entities) | 10.8% | 10.4% | 6.9% | 4.9% | 2024 | Report |
| Pinewood Healthcare | 20.85% | 19.97% | 8.1% | 19.38% | 2024 | Report |
| PPD Development | -0.13% | 3% | 5.3% | 2.3% | 2023 | Report |
| Sanofi: Genzyme Ireland Ltd | 8.2% | 6.3% | 14.4% | -3.2% | 2024 | Report |
| Servier | 7% | 1.8% | -11.5% | -7.6% | 2024 | Report |
| SK biotek | 15.14% | 28.62% | 20.73% | 44.84% | 2024 | Report |
| Smurfit Kappa | 0.8% | 4.3% | -10.8% | 1.2% | 2024 | Report |
| Smurfit Westrock | 8.4% | 5.9% | 56.8% | 68.6% | 2024 | Report |
| Solventum | 10.89% | 6.64% | 29.18% | 0% | 2024 | Report |
| Stafford Bakeries | 5% | 7.78% | 15.61% | -108.33% | 2024 | Report |
| Sulzer Pumps | 10.94% | 4.57% | 94.68% | 87.25% | 2023 | Report |
| Takeda | 0.5% | -0.9% | -0.9% | -15.1% | 2024 | Report |
| Takeda Pharmaceuticals | 19.2% | 19.5% | 28.9% | 17.1% | 2024 | Report |
| Tayto Snacks | 4.79% | 4.22% | 41.62% | 22.75% | 2024 | Report |
| Teva Pharmaceuticals | 12.2% | 1.5% | 37% | 5.2% | 2024 | Report |
| ThermoFisher Scientific | 27.7% | 31.6% | 37% | 64.9% | 2024 | Report |
| Tirlán (formerly Glanbia Ireland) | 8.5% | 6.3% | 27.4% | -11.2% | 2024 | Report |
| Trane Technologies | -15.06% | -27.18% | -85.41% | 13.87% | 2023 | Report |
| Vertiv (formerly E+I Engineering) | 9.91% | 4.5% | -29.92% | -34.63% | 2022 | Report |
| Viatris: McDermott Laboratories | 2.77% | 8.83% | -19.82% | -3.44% | 2024 | Report |
| Viatris: Mylan Teoranta | 13.07% | 14.48% | 25.39% | 16.93% | 2024 | Report |
| Viatris: Rottapharm Limited | 8.72% | 8.51% | 9.94% | -5.28% | 2024 | Report |
| Viatris: Upjohn Manufacturing | 14% | 28.32% | 0.09% | 0.01% | 2024 | Report |
| WuXi Biologics | 15.9% | 14.4% | 28.6% | -1.3% | 2024 | Report |
| WuXi Vaccines | 19.3% | 25.2% | 26.8% | 7.4% | 2024 | Report |
| Xilinx (AMD) | 11.4% | 19.3% | 12.9% | 29.8% | 2024 | Report |
Manufacturing Industry Reports
The most recent report for each company is displayed here. You can click on a company name to view all available information for a specific company and some graphs showing change over time. Note: some fields may have “No Value” returned. This is where the figure was either not reported or not applicable. Please check the full report for the details for the company in question.